- Home
- KRMD vs HGLB Comparison
KRMD vs HGLB Comparison
Compare KRMD & HGLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- HGLB
- Stock Information
- Founded
- KRMD 1980
- HGLB 1998
- Country
- KRMD United States
- HGLB United States
- Employees
- KRMD N/A
- HGLB N/A
- Industry
- KRMD Medical/Dental Instruments
- HGLB Trusts Except Educational Religious and Charitable
- Sector
- KRMD Health Care
- HGLB Finance
- Exchange
- KRMD Nasdaq
- HGLB Nasdaq
- Market Cap
- KRMD 187.5M
- HGLB 176.4M
- IPO Year
- KRMD N/A
- HGLB N/A
- Fundamental
- Price
- KRMD $4.12
- HGLB $7.74
- Analyst Decision
- KRMD Strong Buy
- HGLB
- Analyst Count
- KRMD 5
- HGLB 0
- Target Price
- KRMD $4.50
- HGLB N/A
- AVG Volume (30 Days)
- KRMD 137.2K
- HGLB 91.8K
- Earning Date
- KRMD 03-12-2025
- HGLB 01-01-0001
- Dividend Yield
- KRMD N/A
- HGLB 13.16%
- EPS Growth
- KRMD N/A
- HGLB N/A
- EPS
- KRMD N/A
- HGLB N/A
- Revenue
- KRMD $31,993,796.00
- HGLB N/A
- Revenue This Year
- KRMD $20.04
- HGLB N/A
- Revenue Next Year
- KRMD $14.15
- HGLB N/A
- P/E Ratio
- KRMD N/A
- HGLB N/A
- Revenue Growth
- KRMD 11.57
- HGLB N/A
- 52 Week Low
- KRMD $1.98
- HGLB $6.42
- 52 Week High
- KRMD $4.60
- HGLB $9.45
- Technical
- Relative Strength Index (RSI)
- KRMD 58.45
- HGLB 63.20
- Support Level
- KRMD $3.81
- HGLB $7.35
- Resistance Level
- KRMD $4.21
- HGLB $7.87
- Average True Range (ATR)
- KRMD 0.19
- HGLB 0.12
- MACD
- KRMD -0.00
- HGLB 0.06
- Stochastic Oscillator
- KRMD 64.83
- HGLB 82.27
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About HGLB Highland Global Allocation Fund
Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.